2014
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke 2014, 45: 2160-2236. PMID: 24788967, DOI: 10.1161/str.0000000000000024.Peer-Reviewed Original ResearchConceptsTransient ischemic attackEvidence-based recommendationsIschemic attackCerebral venous sinus thrombosisTimely evidence-based recommendationsAntiphospholipid antibody syndromeVenous sinus thrombosisPrevention of strokeAortic arch atherosclerosisSickle cell diseaseImplementation of guidelinesAntibody syndromeFuture strokeRecurrent strokeAnticoagulation therapyAntiplatelet therapyAntithrombotic therapySinus thrombosisIschemic strokeNoncardioembolic strokeSecondary preventionArterial dissectionHypercoagulable statePatent foramenIntracranial hemorrhage
2004
Type 2 diabetes mellitus and insulin resistance: Stroke prevention and management
Kernan WN, Inzucchi SE. Type 2 diabetes mellitus and insulin resistance: Stroke prevention and management. Current Treatment Options In Neurology 2004, 6: 443-450. PMID: 15461922, DOI: 10.1007/s11940-004-0002-y.Peer-Reviewed Original ResearchType 2 diabetes mellitusDiabetes mellitusInsulin resistanceAntiplatelet therapyIschemic strokeMost patientsGlycemic controlLipid metabolismLowdensity lipoprotein cholesterolRecent ischemic strokeRecurrent ischemic strokeBlood pressure controlFirst-line therapyImpaired glucose toleranceSmooth muscle cell proliferationPrevention of diabetesTight glycemic controlBlood pressure regulationEffects of hyperglycemiaMajor underlying defectMuscle cell proliferationAspirin dailyClopidogrel dailyOccult diabetesMacrovascular disease